PERFORMANCE SHARE UNIT AGREEMENT FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC.Performance Share Unit Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Performance Share Unit Grant Notice for Non-U.S. Participants (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Performance Share Unit Agreement for Non-U.S. Participants, including any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, along with Exhibit A, this “Agreement”), and the Plan, Catalent, Inc. (the “Company”) and the Participant agree as follows.
PERFORMANCE SHARE UNIT AGREEMENT UNDER THE CATALENT, INC. (Performance Period commencing on July 1, 20XX and ending on June 30, 20XX)Performance Share Unit Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Performance Share Unit Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Performance Share Unit Agreement (this “Agreement”), and the Plan, Catalent, Inc. (the “Company”) and the Participant agree as follows.
OPTION AGREEMENT FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC.Option Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Option Grant Notice for Non-U.S. Participants (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Option Agreement for Non-U.S. Participants, including any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”), and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
RESTRICTED STOCK UNIT AGREEMENT FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC.Restricted Stock Unit Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Restricted Stock Unit Grant Notice for Non-U.S. Participants (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Restricted Stock Unit Agreement for Non-U.S. Participants, including any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”) and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
OPTION AGREEMENT UNDER THE CATALENT, INC.Option Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Option Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Option Agreement (this “Agreement”) and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
RESTRICTED STOCK UNIT AGREEMENT UNDER THE CATALENT, INC.Restricted Stock Unit Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Agreement (this “Agreement”) and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.